Attorneys general in 14 states, including Massachusetts, said they will defend state laws that protect access to gender-affirming care, even if that means suing the Trump administration to do so.

President Donald Trump’s day-one executive order attempting to redefine birthright citizenship drew an immediate lawsuit from immigrants’ rights groups, including the ACLU of ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

While a judge for the federal district court in Washington, D.C., temporarily blocked the implementation of the policy until ...